UBE3A (Ubiquitin-protein ligase E3A) variants and mutations

UBE3A (also known as Ubiquitin-protein ligase E3A) is a human protein-coding gene encoding an ubiquitin-protein ligase E3A protein. Its ubiquitin-ligase activity controls turnover of selected neuronal proteins and is subject to maternal-specific expression in many neurons. Loss of the maternal allele causes Angelman syndrome, while increased dosage contributes to neurodevelopmental abnormalities in 15q11-q13 duplication. This analysis covers 481 UBE3A variants and mutations. Of these, 63% have computational variant effect predictions. Disease context includes Angelman syndrome, hereditary disease, and Intellectual disability. Example UBE3A variants include K3R, Q6P, and W9*.

Variant analysis overview

Variant and mutation evidence

Clinical, disease, and population context

Protein structure and variant hotspots

Data sources

Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, ClinGen, MaveDB, LitVar.

Notable UBE3A variants

Examples include K3R, Q6P, W9*, G12V, E20V, R23Q, L32Q, I33M. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.